IFNγ score-based neoadjuvant immunotherapy for stage III melanoma.

The Journal of experimental medicine（2023）

引用 0|浏览0

暂无评分

摘要

In this issue of JEM, Reijers et al. (2023. J. Exp. Med.https://doi.org/10.1084/jem.20221952) demonstrate that pre- and post-treatment IFNγ-related gene expression scores are promising markers for choosing neoadjuvant immunotherapy for stage III melanoma.

查看译文

关键词

neoadjuvant immunotherapy,melanoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要